Developing innovative three-dimensional medical imaging technologies for point of care
Pensievision is developing innovative three-dimensional (3D) medical imaging technologies for point of care, early-stage detection and analysis of cervical cancers. Our technology is favorable over other screening methods for ease of use, accessibility, and cost. Most important, the screening and diagnostics do not require lab results and additional visits to the clinic.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 16, 2018 | Grant | $224.28K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |